Cipla Medpro invests in health tech company Brandmed
SA ranks as the one of the world’s unhealthiest places to live in the Indigo Wellness Index
SA pharmaceutical manufacturer Cipla Medpro, a wholly owned subsidiary of Indian generic giant Cipla, has acquired a 30% stake in local digital health company Brandmed for R65m, it announced on Tuesday. The deal offers Cipla Medpro, which is SA’s third-largest pharmaceutical company operating in the private sector, an opportunity to boost sales of its products for treating noncommunicable diseases, as Brandmed’s system aims to improve patient adherence to their pill-taking schedules. Brandmed has developed a digital system for diagnosing and managing noncommunicable diseases such as hypertension, diabetes, and asthma. It links a Bluetooth-enabled device, such as a blood pressure cuff, to a smartphone app, which delivers regular reports to the patient’s doctor to help manage the patient’s disease. It also triggers the provision of emergency services, if the captured data signals an imminent crisis, such as a stroke. Cipla Medpro CEO Paul Miller said the company will make further i...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.